These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 2777139)

  • 1. Comparison of human normal, full-term, fetal and adult plasminogen by physical and chemical analyses.
    Summaria L
    Haemostasis; 1989; 19(5):266-73. PubMed ID: 2777139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and characterization of the affinity chromatography forms of human Glu- and Lys-plasminogens and plasmins.
    Summaria L; Spitz F; Arzadon L; Boreisha IG; Robbins KC
    J Biol Chem; 1976 Jun; 251(12):3693-9. PubMed ID: 132440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical and chemical properties of the NH2-terminal glutamic acid and lysine forms of human plasminogen and their derived plasmins with an NH2-terminal lysine heavy (A) chain.
    Robbins KC; Boreisha IG; Arzadon L; Summaria L
    J Biol Chem; 1975 Jun; 250(11):4044-7. PubMed ID: 123921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysfunctional plasminogen in full term newborn--study of active site of plasmin.
    Benavent A; Estellés A; Aznar J; Martinez-Sales V; Gilabert J; Fornas E
    Thromb Haemost; 1984 Feb; 51(1):67-70. PubMed ID: 6232730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal plasminogen displays altered cell surface binding and activation kinetics. Correlation with increased glycosylation of the protein.
    Edelberg JM; Enghild JJ; Pizzo SV; Gonzalez-Gronow M
    J Clin Invest; 1990 Jul; 86(1):107-12. PubMed ID: 2365810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal plasminogen Maywood I.
    Robbins KC; Boreisha IG; Godwin JE
    Thromb Haemost; 1991 Nov; 66(5):575-80. PubMed ID: 1803622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transport of urokinase across the intestinal tract of normal human subjects with stimulation of synthesis and/or release of urokinase-type proteins.
    Toki N; Sumi H; Sasaki K; Boreisha I; Robbins KC
    J Clin Invest; 1985 Apr; 75(4):1212-22. PubMed ID: 3921568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysfunctional plasminogen in full-term newborn.
    Estelles A; Aznar J; Gilabert J; Parrilla JJ
    Pediatr Res; 1980 Nov; 14(11):1180-5. PubMed ID: 7192844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrin clot lysis by thrombolytic agents is impaired in newborns due to a low plasminogen concentration.
    Andrew M; Brooker L; Leaker M; Paes B; Weitz J
    Thromb Haemost; 1992 Sep; 68(3):325-30. PubMed ID: 1440499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The primary structure of human plasminogen. I. The NH 2 -terminal sequences of human plasminogen and the S-carboxymethyl heavy (A) and light (B) chain derivatives of plasmin.
    Robbins KC; Bernabe P; Arzadon L; Summaria L
    J Biol Chem; 1972 Nov; 247(21):6757-62. PubMed ID: 4263615
    [No Abstract]   [Full Text] [Related]  

  • 11. Investigation of a congenital abnormal plasminogen, Frankfurt I, and its relationship to thrombosis.
    Scharrer IM; Wohl RC; Hach V; Sinio L; Boreisha I; Robbins KC
    Thromb Haemost; 1986 Jun; 55(3):396-401. PubMed ID: 2944241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of commercially available plasminogen preparations in vitro: purity and reactivity.
    Miyashita C; Heiden M; Leipnitz G; Pindur G; Wenzel E
    Haemostasis; 1988; 18 Suppl 1():121-6. PubMed ID: 3350393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological activation of plasminogen in full term newborn infants.
    Hilali MM; Gilliver BE
    J Clin Pathol; 1984 Nov; 37(11):1264-7. PubMed ID: 6542111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of carcino-fetal proteins: physical and chemical properties of human alpha-fetoprotein.
    Ruoslahti E; Seppälä M
    Int J Cancer; 1971 Mar; 7(2):218-25. PubMed ID: 4996585
    [No Abstract]   [Full Text] [Related]  

  • 15. Immobilized urokinase column as part of a specific detection system for plasminogen species separated by high-performance affinity chromatography.
    Abe I; Ito N; Noguchi K; Kazama M; Kasai K
    J Chromatogr; 1991 Apr; 565(1-2):183-95. PubMed ID: 1874866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The plasminogen-plasmin system. 8. On the mechanism of chemical induction of fibrinolysis. Isolation of a latent plasminogen activator from human plasma.
    Tomikawa M; Abiko Y
    Thromb Diath Haemorrh; 1973 Feb; 29(1):50-62. PubMed ID: 4267738
    [No Abstract]   [Full Text] [Related]  

  • 17. The plasminogen content of commercial preparations and of normal donor plasma in relation to the plasmin content of the 1st international plasmin reference preparation.
    Wolf P
    Thromb Haemost; 1979 Aug; 42(2):582-95. PubMed ID: 159512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of human residual catalase of an acatalasemic patient by isoelectric focusing and sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by electrophoretic blotting and immunodetection.
    Ogata M; Suzuki K; Satoh Y
    Electrophoresis; 1989 Mar; 10(3):194-8. PubMed ID: 2651112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the reliability of plasminogen measurement employing the proactivator-activator converting method.
    Martin M
    Thromb Haemost; 1976 Dec; 36(3):551-65. PubMed ID: 138961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital abnormal plasminogen, Frankfurt I, a cause for recurrent venous thrombosis.
    Scharrer I; Hach-Wunderle V; Wohl RC; Sinio L; Boreisha I; Robbins KC
    Haemostasis; 1988; 18 Suppl 1():77-86. PubMed ID: 2965086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.